Prostate carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Real-time quantitative polymerase chain reaction was performed to evaluate the expression of TTTY15-USP9Y and the prostate cancer-specific antigen (PSA) level.
|
26008593 |
2015 |
Malignant neoplasm of prostate
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer.
|
25188740 |
2014 |
Prostate carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer.
|
25188740 |
2014 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer.
|
25188740 |
2014 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer.
|
25188740 |
2014 |
Coronary Arteriosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The TBL1Y(A) USP9Y(A) haplotype of the Y chromosome, present only in black people of African origin, attributes a favorable lipoprotein pattern, likely to contribute to their reduced susceptibility to coronary heart disease.
|
18511697 |
2008 |
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The TBL1Y(A) USP9Y(A) haplotype of the Y chromosome, present only in black people of African origin, attributes a favorable lipoprotein pattern, likely to contribute to their reduced susceptibility to coronary heart disease.
|
18511697 |
2008 |
Coronary Artery Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The TBL1Y(A) USP9Y(A) haplotype of the Y chromosome, present only in black people of African origin, attributes a favorable lipoprotein pattern, likely to contribute to their reduced susceptibility to coronary heart disease.
|
18511697 |
2008 |
Multiple Myeloma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To investigate lineage-specific chimerism of plasma cells after allogeneic transplantation by real-time PCR based on bi-allelic sequence polymorphism or, in case of female-to-male transplantation, on the detection of the DFFRY gene and to determine its value to quantify minimal residual disease in myeloma patients.
|
16647575 |
2006 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
We tested transcripts of 14 Y chromosomal genes by RT-PCR (TSPY, DAZ, BPY1 and BPY2, PRY, XKRY, CDY1 and CDY2, TTY1 and TTY2, PRKY, RBMY1, DBY and USP9Y), and only transcript of TSPY was detectable in the tumor tissue.
|
16784771 |
2006 |
Neoplasm, Residual
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
To investigate lineage-specific chimerism of plasma cells after allogeneic transplantation by real-time PCR based on bi-allelic sequence polymorphism or, in case of female-to-male transplantation, on the detection of the DFFRY gene and to determine its value to quantify minimal residual disease in myeloma patients.
|
16647575 |
2006 |
Lymphoproliferative Disorders
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Y chromosome instability in lymphoproliferative disorders.
|
12650910 |
2003 |
Congenital absence of germinal epithelium of testes
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
One of these two patients had DFFRY deletion and the other had DBY deletion; their testicular phenotypes were Sertoli cell-only syndrome and hypospermatogenesis, respectively.
|
11695273 |
2001 |
Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
The DFFRY-derived peptide was recognized by an HLA-A1 restricted CTL clone, generated during graft rejection from a female patient with acute myeloid leukemia who rejected HLA-phenotypically identical bone marrow from her father.
|
10648428 |
2000 |